Penumbra Inc (PEN) Chairman, CEO and President Adam Elsesser Sold $1.2 million of Shares

Chairman, CEO and President of Penumbra Inc (30-Year Financial, Insider Trades) Adam Elsesser (insider trades) sold 8,000 shares of PEN on 08/12/2019 at an average price of $149.24 a share. The total sale was $1.2 million.

Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra Inc has a market cap of $5.17 billion; its shares were traded at around $148.50 with a P/E ratio of 481.09 and P/S ratio of 11.39. GuruFocus has detected 2 severe warning signs with Penumbra Inc. .

CEO Recent Trades:

  • Chairman, CEO and President Adam Elsesser sold 8,000 shares of PEN stock on 08/12/2019 at the average price of $149.24. The price of the stock has decreased by 0.5% since.

CFO Recent Trades:

  • CFO and Head of Strategy Sridhar Kosaraju sold 5,000 shares of PEN stock on 08/01/2019 at the average price of $169.36. The price of the stock has decreased by 12.32% since.

For the complete insider trading history of PEN, click here

.